Physician profile
Angelo E Gousse
NPI 1821028259
$32,199.03
in general payments reported to CMS, 2019-2025
36 companies · $276 in 2025
The $276 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $4,210 · 2021: $1,236 · 2022: $567 · 2023: $1,296 · 2024: $407 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,355 · Travel and Lodging: $623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,355.23 |
| Travel and Lodging | $622.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $15,027.63 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $12,204.14 | 2019 | |
| Coloplast Corp | $1,608.59 | 2019-2025 | Titan, Speedicath |
| Axonics, INC. | $840.62 | 2020-2024 | Axonics |
| Boston Scientific Corporation | $554.86 | 2019-2025 | Watchman Flx, Ams 700, Ams 800 Artificial Urinary Sphincter |
| Astellas Pharma US INC | $371.76 | 2019-2023 | Myrbetriq |
| Kerecis Limited | $171.27 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Laborie Medical Technologies Corp. | $163.82 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Rochester Medical Corporation | $154.97 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $129.13 | 2021-2024 | Prolaris |
| C. R. Bard, INC. & Subsidiaries | $112.67 | 2019-2023 | |
| Endo Pharmaceuticals INC. | $107.30 | 2021-2022 | |
| Medtronic, INC. | $74.65 | 2022-2024 | Interstim |
| Abbvie INC. | $71.93 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $70.86 | 2023-2024 | Gemtesa |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $56.32 | 2022-2023 | |
| Mission Pharmacal Company | $53.91 | 2021-2024 | Uribel, Uribel Tabs |
| Tolmar, INC. | $43.21 | 2025 | Eligard, Jatenzo |
| Verity Pharmaceuticals INC. | $41.75 | 2022 | |
| Biosense Webster, INC. | $39.60 | 2025 | Nuvision Ice Catheter, Carto 3 |
| Tolmar Pharmaceuticals, INC. | $38.50 | 2021 | |
| Myovant Sciences INC. | $31.51 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $24.50 | 2023 | Lynparza |
| Bard Access Systems, INC. | $23.02 | 2019 | |
| Merck Sharp & Dohme LLC | $21.56 | 2021 | |
| Angiodynamics, INC. | $20.19 | 2022 | |
| Blue Earth Diagnostics | $19.00 | 2019 | |
| Aytu Biopharma, INC. | $18.18 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $17.95 | 2022 | |
| Olympus America INC. | $17.20 | 2022 | |
| Valencia Technologies Corporation | $15.03 | 2025 | Ecoin Device Kit |
| Urovant Sciences INC | $14.88 | 2022 | |
| Procept Biorobotics Corporation | $13.93 | 2024 | Aquabeam System |
| Urogen Pharma, INC. | $12.88 | 2021 | |
| Rigicon,INC. | $11.71 | 2023 | Rigi10 Malleable Penile Prosthesis |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angelo Gousse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.